Janus Henderson Group PLC Ardelyx, Inc. Transaction History
Janus Henderson Group PLC
- $188 Billion
- Q4 2024
A detailed history of Janus Henderson Group PLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 24,387,941 shares of ARDX stock, worth $130 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
24,387,941
Previous 21,529,880
13.27%
Holding current value
$130 Million
Previous $148 Million
15.0%
% of portfolio
0.07%
Previous 0.08%
Shares
14 transactions
Others Institutions Holding ARDX
# of Institutions
233Shares Held
150MCall Options Held
1.54MPut Options Held
3.08M-
Black Rock Inc. New York, NY17.6MShares$93.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.4MShares$76.6 Million0.0% of portfolio
-
State Street Corp Boston, MA11.6MShares$61.8 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C310.3MShares$55.1 Million0.06% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.6MShares$29.9 Million0.55% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $824M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...